PAPER Liu S, Geng D
SEARCH RESULTS
332389 RESULTS
PAPER Zhang T, Chu Y, Wang Y, Wang Y, Wang J, Ji X, Zhang G, Shi G, Cui R, Kang Y
Testosterone deficiency worsens mitochondrial dysfunction in APP/PS1 mice.
Front Aging Neurosci. 2024;16:1390915. Epub 2024 May 1 PubMed.PAPER Goyal R, Mittal P, Gautam RK, Kamal MA, Perveen A, Garg V, Alexiou A, Saboor M, Haque S, Farhana A, Papadakis M, Ashraf GM
Natural products in the management of neurodegenerative diseases.
Nutr Metab (Lond). 2024 May 16;21(1):26. PubMed.PAPER Aslan Kirazoglu D, Heybeli C, Atcıyurt K, Yigitalp V, Smith L, Veronese N, Rahmati M, Soysal P
The relationship between dehydration and etiologic subtypes of major neurocognitive disorder in older patients.
Eur Geriatr Med. 2024 May 17; PubMed.PAPER Goodman LD, Moulton MJ, Lin G, Bellen HJ
Does glial lipid dysregulation alter sleep in Alzheimer's and Parkinson's disease?
Trends Mol Med. 2024 May 15; PubMed.PAPER Vun DS, Bowers R, McGarry A
Vision-based motion capture for the gait analysis of neurodegenerative diseases: A review.
Gait Posture. 2024 May 7;112:95-107. PubMed.PAPER Shojaei M, Zhou Q, Palumbo G, Schaefer R, Kaskinoro J, Vehmaan-Kreula P, Bartenstein P, Brendel M, Edbauer D, Lindner S
Development and Preclinical Evaluation of a Copper-64-Labeled Antibody Targeting Glycine-Alanine Dipeptides for PET Imaging of C9orf72-Associated Amyotrophic Lateral Sclerosis/Frontotemporal Dementia.
ACS Pharmacol Transl Sci. 2024 May 10;7(5):1404-1414. Epub 2024 Apr 25 PubMed.PAPER Siafarikas N
Personalized medicine in old age psychiatry and Alzheimer's disease.
Front Psychiatry. 2024;15:1297798. Epub 2024 May 1 PubMed.PAPER Yi LX, Zeng L, Wang Q, Tan EK, Zhou ZD
Reelin links Apolipoprotein E4, Tau, and Amyloid-β in Alzheimer's disease.
Ageing Res Rev. 2024 May 14;98:102339. PubMed.PAPER Liu J, Wang Y, Zhao Y, Pan H, Liu Z, Xu Q, Lu S, Jiang H, Wang J, Sun Q, Tan J, Yan X, Li J, Tang B, Guo J
Comprehensive variant analysis of phospholipase A2 superfamily genes in large Chinese Parkinson' s disease cohorts.
Mech Ageing Dev. 2024 May 14;219:111940. PubMed.Joel Blanchard, Braxton Schuldt on Does a Rare Fibronectin Variant Protect Against APOE4?
COMMENT APOE4 is the strongest risk factor for Alzheimer’s disease. APOE4 homozygosity was recently identified as a distinct, highly penetrant form of AD. However, a small percentage of APOE4 homozygotes live cognitively normal lives into their 80s and beyond (Fo
Does a Rare Fibronectin Variant Protect Against APOE4?
RESEARCH NEWS 2024-05-16 Research News APOE4 strongly increases the risk of sporadic Alzheimer’s disease. Yet some carriers evade the disease entirely. Now, scientists led by Richard Mayeux, Caghan Kizil, and Badri Vardarajan of Columbia University in New York peg some of that pr
PAPER Thornton P, Reader V, Digby Z, Smolak P, Lindsay N, Harrison D, Clarke N, Watt AP
Reversal of High Fat Diet-Induced Obesity, Systemic Inflammation, and Astrogliosis by the NLRP3 Inflammasome Inhibitors NT-0249 and NT-0796.
J Pharmacol Exp Ther. 2024 Feb 15;388(3):813-826. PubMed.PAPER Smolak P, Nguyen M, Diamond C, Wescott H, Doedens JR, Schooley K, Snouwaert JN, Bock MG, Harrison D, Watt AP, Koller BH, Gabel CA
Target Cell Activation of a Structurally Novel NOD-Like Receptor Pyrin Domain-Containing Protein 3 Inhibitor NT-0796 Enhances Potency.
J Pharmacol Exp Ther. 2024 Feb 15;388(3):798-812. PubMed.Steven Sweeney
Aliada TherapeuticsBoston, United States
Current Filters
No filters selected